LncRNA PCAT18: Roles and Mechanisms in Human Cancers
The lncRNA PCAT18 behaves differently across cancers, making it a potential biomarker once clinical studies validate its use.
This review summarizes the role of lncRNA PCAT18 across multiple cancer types including leukemia, highlighting its function as an oncogenic or tumor-suppressive regulator depending on cancer context. PCAT18's role in androgen signaling and leukemia makes it a potential biomarker and therapeutic target, though clinical validation is lacking.
What the study was
- Study design
- Narrative review
- Population
- Cancer cell lines and patients (PCa, lung, breast, digestive cancers, leukemia)
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Wiley Interdisciplinary Reviews: RNA
Why it surfaced
Review of emerging lncRNA biomarker in hematologic malignancies; informative for genomics pipeline but no original clinical data.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.